4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000175
Chairperson & CEO sold 9,500 shares at an average $594.78 ($5,650,415)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
10 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-29 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $117.76 | $1,118,720 | 333,943 | I |
| 2026-10-29 | Sale : show line 2 in the form 10b5-1 | −53 | $590.43 | $31,293 | 333,890 | I |
| 2026-10-29 | Sale : show line 3 in the form 10b5-1 | −1,104 | $591.90 | $653,460 | 332,786 | I |
| 2026-10-29 | Sale : show line 4 in the form 10b5-1 | −1,563 | $592.97 | $926,810 | 331,223 | I |
| 2026-10-29 | Sale : show line 5 in the form 10b5-1 | −1,540 | $593.88 | $914,574 | 329,683 | I |
| 2026-10-29 | Sale : show line 6 in the form 10b5-1 | −1,248 | $594.89 | $742,429 | 328,435 | I |
| 2026-10-29 | Sale : show line 7 in the form 10b5-1 | −1,678 | $595.88 | $999,886 | 326,757 | I |
| 2026-10-29 | Sale : show line 8 in the form 10b5-1 | −1,355 | $596.86 | $808,746 | 325,402 | I |
| 2026-10-29 | Sale : show line 9 in the form 10b5-1 | −919 | $597.66 | $549,245 | 324,483 | I |
| 2026-10-29 | Sale : show line 10 in the form 10b5-1 | −40 | $599.30 | $23,972 | 324,443 | I |
| Open-market sales · 9,500 sh · avg $594.78 · $5,650,415 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-29 | Exercise or conversion : show line 11 in the form 10b5-1 Stock Option | −9,500 | 128,910 | I |
Loading xslF345X06/primarydocument.xml…